Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
Apogee Therapeutics Inc. (NASDAQ : APGE) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
Quote
| Last: | $133.995 |
|---|---|
| Change Percent: | -0.04% |
| Open: | $134.01 |
| Close: | $133.995 |
| High: | $134.2 |
| Low: | $133.935 |
| Volume: | 1,451,792 |
| Last Trade Date Time: | 07/17/2026 03:46:01 pm |
Stock Data
| Market Cap: | $4,474,975,000 |
|---|---|
| Float: | 36,961,244 |
| Insiders Ownership: | 2.65% |
| Institutions: | 54 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.apogeetherapeutics.com |
| Country: | US |
| City: | Waltham |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about Apogee Therapeutics Inc. (NASDAQ: APGE).
